Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elis Capital/Financing Update 2019

Apr 2, 2019

1280_prs_2019-04-02_41b0e39a-d924-410c-b561-5f83c67ad3ae.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Availability of the first supplement to the base prospectus of Elis' Euro Medium Term Note (EMTN) Programme

Saint-Cloud, April 2, 2019 – Elis (the "Company") has issued a first supplement to the base prospectus of its EUR 3,000,000,000 Euro Medium Term Note Programme (visa n°19-116 of the AMF dated March 26, 2019).

Such first supplement was granted the visa no. 19-127 on April 1st, 2019.

Copies of the base prospectus and if its first supplement may be obtained, free of charge, at the registered office of the Company, 5 boulevard Louis Loucheur, 92210 Saint-Cloud, France.

The base prospectus and its first supplement are also available on the AMF's website (www.amffrance.org) and on the Company's website (www.corporate-elis.com).

Contact

Nicolas Buron Investor Relations Director – Phone: +33 1 75 49 98 30 - [email protected]

Audrey Bourgeois Investor Relations – Phone: +33 1 75 49 96 25 - [email protected]